Quasi-LD-Targeted and ONOO--Responsive Fluorescent Probe for Investigating the Interaction of Nonalcoholic Fatty Liver with Drug-Induced Liver Injury.

Hepatic lipid droplets (LDs) and peroxynitrite (ONOO-) levels are closely related to nonalcoholic fatty liver disease (NAFLD). Additionally, some drug-induced liver injury (DILI) is often associated with ONOO-. Here, we constructed and screened the quasi-LDs-targeted and ONOO--responsive fluorescent probe MBDP-Py+ to investigate the interaction of NAFLD with DILI. By monitoring the upregulation of the ONOO- levels and the accumulation of LDs, MBDP-Py+ was more sensitive and efficient than tissue staining and serum markers detection in evaluating the early toxicity of NAFLD and diagnosing the anticancer-DILI. More importantly, the sensitive enhancement of fluorescence signals demonstrated that in different stages of NAFLD, the dominant element of liver injury was different in the NAFLD combined with DILI mice models. As the degree of NAFLD deepens, the synergistic effect of the two will lead to more serious liver damage.

[1]  Jian Zhang,et al.  BODIPY-based fluorescent probe for cysteine detection and its applications in food analysis, test strips and biological imaging. , 2023, Food chemistry.

[2]  Yijia Liu,et al.  Dual-Channel Fluorescent Probe for Detecting Viscosity and ONOO- without Signal Crosstalk in Nonalcoholic Fatty Liver. , 2022, Analytical chemistry.

[3]  Dai-Wen Pang,et al.  BOIMPY-Based NIR-II Fluorophore with High Brightness and Long Absorption beyond 1000 nm for In Vivo Bioimaging: Synergistic Steric Regulation Strategy. , 2022, ACS nano.

[4]  Yang Shen,et al.  Advances in Optical Imaging of Nonalcoholic Fatty Liver Disease. , 2022, Chemistry, an Asian journal.

[5]  Soo-Jin Lee,et al.  Highly Sensitive Two-Photon Lipid Droplet Tracker for In Vivo Screening of Drug Induced Liver Injury. , 2022, ACS sensors.

[6]  He He,et al.  Loss of Sam50 in hepatocytes induces cardiolipin‐dependent mitochondrial membrane remodeling to trigger mtDNA release and liver injury , 2022, Hepatology.

[7]  Guomin Xia,et al.  H‐Dimeric Nanospheres of Amphipathic Squaraine Dye with an 81.2% Photothermal Conversion Efficiency for Photothermal Therapy , 2022, Advanced Functional Materials.

[8]  Fawei Zhu,et al.  Evaluation of Nitric Oxide Fluctuation Via a Fast, Responsive Fluorescent Probe in Idiopathic Pulmonary Fibrosis Cells and Mice Models. , 2022, Analytical chemistry.

[9]  Zhuoyue Song,et al.  Exploiting the Twisted Intramolecular Charge Transfer Effect to Construct a Wash-Free Solvatochromic Fluorescent Lipid Droplet Probe for Fatty Liver Disease Diagnosis. , 2022, Analytical chemistry.

[10]  Yong Ye,et al.  Recent advances in multifunctional fluorescent probes for viscosity and analytes , 2022, Coordination Chemistry Reviews.

[11]  Xiaojing Liu,et al.  Dynamic Adjust of Non‐Radiative and Radiative Attenuation of AIE Molecules Reinforces NIR‐II Imaging Mediated Photothermal Therapy and Immunotherapy , 2022, Advanced science.

[12]  Xiaobing Zhang,et al.  Highly Selective Fluorescent Probe Design for Visualizing Hepatic Hydrogen Sulfide in the Pathological Progression of Nonalcoholic Fatty Liver. , 2021, Analytical chemistry.

[13]  Michael E. Dunham,et al.  Detection of pancreatic cancer by indocyanine green‐assisted fluorescence imaging in the first and second near‐infrared windows , 2021, Cancer communications.

[14]  Kecheng Zhang,et al.  Ultrabright and Highly Polarity‐Sensitive NIR‐I/NIR‐II Fluorophores for the Tracking of Lipid Droplets and Staging of Fatty Liver Disease , 2021, Advanced Functional Materials.

[15]  Jianjun Du,et al.  Molecular Design of Monochromophore-Based Bifunctional Photosensitizers for Simultaneous Ratiometric Oxygen Reporting and Photodynamic Cancer Therapy. , 2021, Analytical chemistry.

[16]  N. Wang,et al.  Endogenous peroxynitrite activated fluorescent probe for revealing anti‐tuberculosis drug induced hepatotoxicity , 2021, Chinese Chemical Letters.

[17]  Yongqing Zhou,et al.  Exploring the Changes of Peroxisomal Polarity in the Liver of Mice with Nonalcoholic Fatty Liver Disease. , 2021, Analytical chemistry.

[18]  Juyoung Yoon,et al.  Rational Design of Highly Selective Near-Infrared Two-Photon Fluorogenic Probe for Imaging Orthotopic Hepatocellular Carcinoma Chemotherapy. , 2021, Angewandte Chemie.

[19]  Li-Ya Niu,et al.  Visualizing the Underlying Signaling Pathway Related to Nitric Oxide and Glutathione in Cardiovascular Disease Therapy by a Sequentially Activated Fluorescent Probe. , 2021, Analytical chemistry.

[20]  Jia Li,et al.  Fluorescent probes for the imaging of lipid droplets in live cells , 2021 .

[21]  Ji-ting Hou,et al.  Fluorescent detectors for hydroxyl radical and their applications in bioimaging: A review , 2020 .

[22]  Xiaobing Zhang,et al.  A high-selectivity fluorescent reporter toward peroxynitrite in coexisting nonalcoholic fatty liver and drug induced liver diseases model. , 2020, Analytical chemistry.

[23]  Juyoung Yoon,et al.  An Activatable AIEgen Probe for High-Fidelity Monitoring of Overexpressed Tumor Enzyme Activity and Its Application to Surgical Tumor Excision. , 2020, Angewandte Chemie.

[24]  Wei Zhang,et al.  Versatile fluorescent probes for visualizing superoxide anion in living cells and in vivo. , 2020, Angewandte Chemie.

[25]  Juyoung Yoon,et al.  Sensors, Imaging Agents, and Theranostics to Help Understand and Treat Reactive Oxygen Species Related Diseases , 2019, Small Methods.

[26]  Peng Yin,et al.  SABER enables amplified and multiplexed imaging of RNA and DNA in cells and tissues , 2019, Nature Methods.

[27]  Xiaobing Zhang,et al.  De Novo Design of Chemical Stability Near-Infrared Molecular Probes for High-Fidelity Hepatotoxicity Evaluation In Vivo. , 2019, Journal of the American Chemical Society.

[28]  Hongliang Li,et al.  Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases , 2018, Advanced science.

[29]  Timothy D. Imler,et al.  Patients With Chronic Liver Disease Suggestive of Nonalcoholic Fatty Liver Disease May Be at Higher Risk for Drug-Induced Liver Injury. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[30]  J. Olzmann,et al.  Dynamics and functions of lipid droplets , 2018, Nature Reviews Molecular Cell Biology.

[31]  I. Wilson,et al.  Paracetamol metabolism, hepatotoxicity, biomarkers and therapeutic interventions: a perspective. , 2018, Toxicology research.

[32]  A. Wu,et al.  A Ultrasensitive Near‐Infrared Fluorescent Probe Reveals Pyroglutamate Aminopeptidase 1 Can Be a New Inflammatory Cytokine , 2018, Advanced science.

[33]  Safacan Kolemen,et al.  Reaction-based BODIPY probes for selective bio-imaging , 2018 .

[34]  C. Hunt,et al.  Drug rechallenge following drug‐induced liver injury , 2017, Hepatology.

[35]  Jun Yu,et al.  Animal models of non‐alcoholic fatty liver disease: current perspectives and recent advances , 2016, The Journal of pathology.

[36]  E. Tsochatzis,et al.  The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). , 2016, Metabolism: clinical and experimental.

[37]  B. Vincenzi,et al.  Drug-induced hepatotoxicity in cancer patients - implication for treatment , 2016, Expert opinion on drug safety.

[38]  Fang Zeng,et al.  A two-photon fluorescent sensor revealing drug-induced liver injury via tracking γ-glutamyltranspeptidase (GGT) level in vivo. , 2016, Biomaterials.

[39]  I. Bergheim,et al.  In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD) , 2013, International journal of molecular sciences.

[40]  B. Fromenty.  Drug-induced liver injury in obesity. , 2013, Journal of hepatology.

[41]  Neil Kaplowitz,et al.  Liver biology and pathobiology , 2006, Hepatology.